| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.00039 | 1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |